This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0530U only for LiquidHallmark® from Lucence Health Inc. This test analyzes circulating tumor DNA (ctDNA) in plasma using next–generation sequencing (NGS) to detect mutations in 77 genes, identify eight gene fusions, and assess microsatellite instability and tumor mutation burden, providing an interpretive report with therapy recommendations.
For clinical responsibility, terminology, tips and additional info
start codify free trial.